> Poster - Poster Session

Friday May 24, 2024 | 17:45 to 20:00
Room: Regency


Jade Montpetit
Senescence unveiled: a signature approach to treatment response in ovarian cancer patient avatars

Bianca Ribeiro de Souza
Refining prognosis of endometrioid ovarian carcinoma subtypes using hormone receptors expression 

Oluwatobi M. Agbede
circSKA3 is overexpressed in high-grade serous carcinoma and exerts tumor-promoting effects

Kathleen I Pishas
Delving deep: Uncovering the genomic mechanisms and proteome landscape driving low grade serous ovarian carcinoma

Mie Jareid
Fusion transcripts in high-grade serous carcinoma

Emily Tomas
Distinct cell signalling alterations during epithelial ovarian cancer metastasis elucidated by spheroid and organoid analysis

Laurence Faucher-Giguère
A single H/ACA snoRNA promotes ovarian tumour aggressiveness by repressing the translation of genes associated with the Wnt pathway

Yalun Zhu
Loss of LATS1 and LATS2 enhances stemness and promotes the formation of an immunosuppressive tumor microenvironment in ovarian cancer

Vidushi Madaan
ISGylation enhances double-stranded RNA-induced interferon response and NFkB signaling in fallopian tube epithelial cells

Kattreen Hanna
Impact of cholesterol on cell migration and ciability in high grade serous ovarian cancer cell lines

Alicia Canuel
Interaction of the Cdc42 effector MRCK-Alpha with the RhoA selective GEF-H1 in ovarian cancer cells.

YangXin Fu
Targeting RNA methyltransferase NSUN2 in epithelial ovarian cancer

Sylvia Cheng
Characterization of histone deacetylase inhibitor (HDACi) activity on ovarian clear cell carcinoma (OCCC) cell line spheroids

Mary Rhodes
High-resolution profiling of total RNA in single cells reveals differentiation trajectories of primary human fallopian tube epithelium

Zoé Gerber
Study of the immune microenvironment rewiring induced by chemotherapy in ovarian cancer

Erin Fletcher
Investigating the therapeutic potential of NLRC5 to restore MHC class I expression and diversity in ovarian cancer cells

Carlos M Telleria
Development of human tumor cell line-derived xenograft mice models representing rare histopathological subtypes of epithelial ovarian carcinoma

David W Andrews
Organoid models for predicting drug responses in high grade serous cancer

Yuchen Ding
The pulmonary metastasis assay (PuMA), a tool to study novel therapies for ovarian cancer: example, EO3001 in clear cell carcinoma

Daisuke Inoue
Plasma gelsolin-induced fibroblast activation: Insights from an in vitro study

Kaitlyn Quinlan Quinlan
Investigating in vivo effects of aberrant SKP1 expression on chromosomal instability in tubo-ovarian, high grade serous cancer

Charles Trelford
LKB1 and STRAD promote epithelial ovarian cancer spheroid cell invasion

Sabrina Ritch
Exploring the therapeutic benefit of novel inhibitors of the small GTPase Ran in human ovarian cancer patient samples

Dane A Cheasley
High throughput synergistic discovery of new therapies for low-grade serous ovarian carcinoma

Trevor Shepherd
Development of novel small molecule inhibitors targeting the stress kinase LKB1 as a therapeutic target in EOC metastasis

Flavie Lévesque
Exploring the therapeutic potential of BET and PKMYT1 inhibitors combination in ovarian cancer

Ben Forgie
The HIV protease inhibitor nelfinavir increases the sensitivity of ovarian cancer cells to cisplatin

Sara K. Crooks
L-Rham: gathering the evidence for a new treatment option for tubo-ovarian, high-grade serous cancer patients

Chiara Gottheil
Examining the diagnostic process for ovarian cancer in Nova Scotia: a linked administrative data study

Gurdial Dhillon
Molecular characterization of ovarian carcinosarcoma reveals heterogeneous oncogenic mechanisms

Alexandra M Lukey
Exploring the acceptability of risk-reducing salpingectomy for people at high lifetime risk of ovarian cancer: The patient perspective

Isaline Bontemps
Microfluidics based culture and treatment of micro-dissected tissues, a novel ex vivo models to predict clinical response to carboplatin-paclitaxel chemotherapy in high-grade serous ovarian cancer patients

Dardan Konjusha
FANCI L604F as a novel ovarian cancer predisposing gene

Blane Gebreyes
Identification and functional characterization of the cancer-initiating cell population in human ovarian clear cell carcinoma (occc) lines

Sylvia Lauks
Fc3TSR remodels the tumor microenvironment and enhances the efficacy of immunotherapies in a preclinical model of advanced stage ovarian cancer

M. Sharon Stack
"Cagemates with benefits: co-housing of aged with young mice reduces age-associated ovarian cancer peritoneal metastatic tumor burden

Warwick S. Pitman
Investigating the effect of Type 1 IFN response in malignancy progression and development of tumour microenvironment

© 2024 CCOCR 2024